Last reviewed · How we verify

NCT03610295

Prophylactic Peripheral Iridectomy Prevents Aphakic Angle-closure Glaucoma

Completed NA Last updated 12 March 2019
What this trial tests

NA trial testing PPI group in Congenital Cataract in 87 participants. Completed in 5 March 2019.

Timeline
2 August 2018
Primary endpoint
5 March 2019
5 March 2019

Quick facts

Lead sponsorZhongshan Ophthalmic Center, Sun Yat-sen University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment87
Start date2 August 2018
Primary completion5 March 2019
Estimated completion5 March 2019
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Who can join

Adults 2 Months to 24 Months, any sex, with Congenital Cataract or Aphakic Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a retrospective, nonrandomized comparative trial with historical control to investigate the safety and efficacy of a novel progressive grasping peripheral iridectomy (PGPI) surgical method in preventing aphakic angle-closure glaucoma (AACG) following congenital cataract surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Congenital Cataract

Currently open trials in the same condition.

Other Zhongshan Ophthalmic Center, Sun Yat-sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03610295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing